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Antibody  responses of mice to the  terpolymer of L-glutamic acidS°-L-alaninea°-L  - 
tyrosine  1° (GAT) 1 are controlled by an H-2-1inked immune response (Ir) gene(s). The 
lack of response in nonresponder mice (H-2p'q's) immunized with soluble GAT appears 
to  be  due  to  a  preferential  stimulation  of GAT-specific suppressor  T  cells  which 
inhibit activation of helper T  cells (1-3). However, GAT-specific helper T  cells can be 
demonstrated in nonresponder mice immunized with GAT complexed to methylated 
bovine serum albumin (GAT-MBSA) or GAT-bearing macrophages (GAT-Mth) (2-4). 
Several observations indicate that the Ir gene defect is not expressed in Mq~, at least 
in  responses  to  GAT.  First,  responder  and  nonresponder  Mth  bind  comparable 
amounts  of GAT  in  vitro  (5,  6).  Second,  allogeneic  nonresponder  and  syngeneic 
responder GAT-M~ stimulate  comparable primary IgG plaque-forming cell  (PFC) 
responses by responder  lymphoid  cells  in  vitro  (6).  Third,  nonresponder  GAT-Mq~ 
stimulate GAT-specific helper T  cells in responder mice in vivo that function in vitro 
only  when  stimulated  with  GAT  on  Mt~  syngeneic  with  the  Mt  h  used  for  initial 
immunization  (6,  7). 2 In  addition  to  these  genetically restricted  immune  helper  T 
cells,  genetically unrestricted,  but  antigen-specific, radiosensitive suppressor T  cells, 
which suppress primary PFC responses stimulated by Mth that are genetically unre- 
lated to those which induced the restricted helper T  cells, are present in these immune 
T-cell populations (8). 
By contrast, Ir gene products may be involved in mediating genetic restrictions in 
M~-T cell interactions in other systems.  (Responder  ×  nonresponder)F1  guinea pig 
T  cells  develop  DNA  synthetic  responses  to  antigens  under  Ir gene  control  when 
antigen  is presented  on responder,  but  not  nonresponder,  parental  M4~ (9).  Similar 
observations have been made with antigens under Ir gene control in murine delayed 
hypersensitivity responses in vivo (10)  and primary and secondary PFC responses in 
vitro  (11,  12). These observations led  to the hypothesis  that  the  Ir gene product  is 
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functionally expressed in Mq~, and nonresponder Mq~ lacking this product are unable 
to present antigen in an immunogenic form to stimulate T  cells (13). 
In  the  GAT-system,  virgin  (responder  ×  nonresponder)F1  spleen  cells  develop 
comparable primary PFC responses to both parental and unrelated third party GAT- 
M~.  F1 spleen cells from mice immunized with responder or nonresponder parental 
GAT-Mq~ develop secondary responses only when stimulated with the parental GAT- 
Mff used for immunization or F1 GAT-M~ (14).  These results are entirely consistent 
with  the restrictions on  Mth-immune helper T-cell interactions  previously observed 
(6).  However, Ft mice immunized with soluble GAT develop secondary responses in 
vitro only when stimulated with responder parental or F1 GAT-Mth. 
Thus, a  contradiction  exists between  (a)  the ability of nonresponder GAT-Mth to 
stimulate  primary responses  in  both  parental  responder  and  (responder  ×  nonre- 
sponder)F1 spleen cells, and to prime these mice such that development of secondary 
responses is restricted to the nonresponder GAT-Mth, and (b) the failure of spleen cells 
from Fx  mice primed  with  soluble  GAT to  develop secondary  responses  to  nonre- 
sponder  GAT-Mq~.  This  latter  observation  is  comparable with  the  concept  that  Ir 
gene(s)  function  may be expressed in  Mff in  the GAT system under  some circum- 
stances. Alternatively, the physical state of the GAT used for immunization, soluble 
GAT vs. GAT-Mth, may be crucial in the priming process and the subsequent response 
patterns of immune F1 spleen cells to parental GAT-Mth in vitro. 
To  analyze  the  paradox  described  above  we  have  examined  secondary  PFC 
responses by (responder  ×  nonresponder)F1 spleen cells from mice immunized with 
parental responder, nonresponder, and F1 GAT-Mq~ and the effect of injecting soluble 
GAT simultaneously with GAT-Mt~ on these response patterns. The data demonstrate 
that  the response patterns  of immune Ft spleen  cells are strictly dependent  on  the 
physical  state of the  GAT used  for immunization  and  that  suppressor T  cells  are 
stimulated in F1 mice immunized with soluble GAT. 
Materials and Methods 
Mice.  C57BL/10  (H-2b), DBA/2  (H-2d), DBA/1  (H-2q), C3H/He (H-2k), (C57BL/10  × 
DBA/2)Fa  (H-2b/a), and  (C57BL/10  ×  DBA/I)Fx  (H.2b/q) mice were bred  in  the  animal 
facility in the Yalem Building at The Jewish Hospital of St. Louis. All mice were maintained 
on laboratory chow and water ad libitum and used at  10-20 wk old.  In a single experiment, 
mice were sex- and age-matched. DBA/1  mice are nonresponders to GAT; all other mice are 
responder strains. 
Antigens, Culture System, and Hemolytic Plaque Assay.  GAT (Miles  Laboratories, Inc., Miles 
Research Products, Elkhart, Ind.; lot 4, mol wt ~-45,000), was prepared as previously described 
for use as soluble GAT or GAT-MBSA in culture (15), preparing GAT-Mth (5, 6), and coupling 
to sheep erythroeytes for use as indicator cells in the PFC assay (15). Spleen cells at 107 eells/ml 
(or at other cell densities  as indicated) in completely supplemented Eagle's minimal essential 
medium containing  10% fetal calf serum (Reheis  Chemical Co., Kankakee, Ill.;  lot M26302) 
were incubated with the indicated GAT-M~ as 1-ml cultures under modified Mishell-Dutton 
conditions (16). In some experiments, primed (C57BL/10 ×  DBA/1)FI spleen cells were treated 
with anti-Thy 1.2 serum plus guinea pig serum as a source of complement (C) to deplete T 
cells. IgG GAT-specific PFC responses were assayed using the slide modification of the Jerne 
hemolytic plaque assay (15). 
Preparation of GA T-Mdp and Immunization of Mice.  The preparation of GAT-Mq~ using peptone- 
induced  peritoneal  exudate  has  been  described  in  detail  previously  (5,  6).  F1  mice  were 
immunized by i.p. injection of:  (a) 3-4  ×  106 of the appropriate GAT-Mff (bearing ---25 ng 
GAT/10  e cells); (b)  I0 #g GAT in a mixture of magnesium aluminum hydroxide gel (Maalox; 
William  H.  Rorer,  Inc.,  Ft.  Washington,  Pa.)  and  pertussis  vaccine  (Eli  Lilly  and  Co., 1284  SUPPRESSOR  T  CELLS  IN  FI SPLEEN  CELLS 
TABLE  I 
PFC Responses to GA T by Responder ×  Responder (C57BL/10  ×  DBA/2) Fx and Re,~ponder × 
Nonresponder (C57BL/ IO ×  DBA/ l)Fx Spleen Cells Stimulated by Parental and Ft GA T-Mck 
Spleen ceils 
Day 5 IgG GAT-specific PFC/cuhure* 
C57BL/10  DBA/2  DBA/1  (C57BL/10  (C57BL/10 
Mth  Mq,  Mff  ×  DBA/2)F~  ×  DBA/1)F~ 
M~  M~ 
(C57BL/10  ×  DBA/2)F1 
Virgin  210  280  290  260  NI)~: 
GAT primed§  420  430  20  570  ND 
Primed with (C57BL/10  ×  DBA/2)F1  280  250  30  240  ND 
GAT-M0{I 
(C57BL/10  ×  DBA/I)F~ 
Virgin  240  240  260  ND  320 
GAT primed§  240  <10  <10  ND  200 
Primed with (C57BL/10  X DBA/I)FI  610  <10  540  ND  670 
GAT-M~,]I 
GAT-MBSA primed¶  640  10  840  ND  700 
* Virgin or immune (C57BL/10  ×  DBA/2)F~ or (C57BL/10  ×  DBA/I)FI spleen cells at  l0 7 cells/culture 
were incubated with 5 ×  104 of the indicated GAT-M~ bearing -~1 ng GAT/105 cells. 
~: ND, not done. 
§ Mice were immunized 28 days previously by intraperitoneal  injection of 10 p,g GAT in Maalox-pertussis. 
II Mice were immunized  28 days previously by intraperitoneal  injection of 4  ×  106 of the indicated  Md~ 
bearing ~30 ng GAT/106 cells. 
¶ Mice were immunized 28 days previously by intraperitoneal  injection of l0 p.g GAT as GAT-MBSA. At 
culture initiation, all these spleen cells had <30 IgG GAT-specific PFC/107 ceils. 
Indianapolis, Ind.) (15);  (c)  10 pg GAT as GAT-MBSA; or, (d) GAT-M~ or GAT-MBSA plus 
10 #g soluble GAT.  PFC  responses by  immune  spleen cells in  vitro 21-35  days later were 
stimulated with 7 or 5  ×  104 M~ bearing 1-2 ng GAT. In some experiments, MqJ were pulsed 
in vivo with GAT by injecting 10 #g GAT (containing 1% 125I-GAT) into peritoneal cavities of 
mice 3 days after injection of 1.5 ml 10% sterile proteose peptone. After 1 h, peritoneal exudate 
cells were harvested, washed three times with Hanks' balanced salt solution, adjusted to 5  x 
105 cells/ml, and added to cultures in 0.1  ml volumes. GAT bound per 5  X  104 cells under 
these conditions ranged from 1.5 to 4.0 ng. 
Results 
PFC Responses to GA T by (Responder  ×  Responder) F1 and (Responder  ×  Nonresponder)Fa 
Spleen Cells Stimulated by Parental and Fa GA T-Mdo.  Previous studies demonstrated that 
(responder  ×  nonresponder)F1 spleen cells from mice immunized with soluble GAT 
in vivo responded to responder parental and  F1 GAT-M~, but  not  to nonresponder 
parental  GAT-Mq~  in  vitro  (14).  These  studies  were  extended  to  spleen  cells from 
(responder C57BL/10  ×  responder  DBA/2)F1  mice  immunized  with  soluble GAT 
and  (responder  ×  responder)F1  and  (responder  C57BL/10  ×  nonresponder 
DBA/1)F1  spleen  cells  from  animals  immunized  with  the  syngeneic  F1  GAT-Mdp 
(Table I). First, virgin Fa spleen cells developed comparable primary PFC responses 
to  all GAT-M~  tested.  Second,  (responder  X  responder)F1  spleen  cells from  mice 
immunized  with  soluble GAT  or  F1  GAT-Mq~  responded  to  F1  and  both  parental 
GAT-M~, but failed to respond to the unrelated, third party DBA/1 GAT-Mg,. Thus, 
these immune Ft spleen cells exhibit genetic restrictions requiring syngenicity between 
the immunizing and stimulating GAT-M~, as observed previously (6) and, in contrast 
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ary  responses  of comparable  magnitude  to  either  parental  GAT-M<h.  Third,  as 
observed  previously  (14),  (responder  ×  nonresponder)F1  spleen  cells  from  mice 
immunized  with  soluble  GAT  responded  to  FI  or  responder  parental,  but  not 
nonresponder parental or unrelated third party, GAT-Mq~. However, if these F1 mice 
were immunized with F1 GAT-Mq~ or GAT-MBSA, their spleen cells responded to F1 
and both parental GAT-M<h, but not third party DBA/2 GAT-Mth. Thus, (responder 
×  nonresponder)F1 spleen cells exhibit restrictions in secondary responses with regard 
to unrelated third  party GAT-M<h regardless of how the spleen cells were primed. 
However, immunization  with  F1  GAT-Mth or GAT-MBSA,  in  contrast  to  soluble 
GAT, produced significantly different response patterns suggesting that the physical 
state  of  the  GAT  used  for  immunization  (soluble  vs.  insolubilized)  is  a  major 
determining factor in whether the immune F1 spleen cells respond to nonresponder 
parental GAT-M<h. 
Effects of Soluble GA T on Response Patterns to Parental and F1 GA T-M~ and GA T-MBSA 
in (Responder ×  Nonresponder)F1 Mice.  The hypothesis tested with the experiments in 
Table II was  that  simultaneous administration  of soluble GAT and  parental  or Fa 
GAT-M<h or GAT-MBSA to  (responder  ×  nonresponder)F1 mice will  convert  the 
response pattern normally induced by that immunizing agent to the response pattern 
normally induced by soluble GAT. Virgin  F1 spleen cells and  spleen cells from F1 
mice primed with soluble GAT responded as observed previously. It is possible that 
these results reflect an artifact induced by pulsing Mq~ with GAT in vitro at 4°C in 
serum-free medium at _>pH 9. Therefore, C57BL/10 and DBA/1  peritoneal exudate 
M<  h were  pulsed  under  physiological conditions  by  injecting  10 /lg  GAT  into  the 
peritoneal cavity and  harvesting the cells  1 h  later.  These Mq~ bound quantities of 
GAT comparable to M<h pulsed in vitro and stimulated responses in virgin and GAT- 
primed Fx spleen cells comparable to those stimulated by in vitro pulsed parental Mq~ 
(Table II,  exp.  1 and  2).  Thus,  the  ability of nonresponder parental  GAT-Mth to 
stimulate  primary  responses  and  their  failure  to  stimulate  secondary responses  in 
GAT-primed F1 spleen cells was not due to an artifact, such as denaturation of GAT, 
induced by the conditions employed for in  vitro pulsing of Mq~. As expected from 
previous  experiments  (14),  spleen  cells  from  F1  mice  primed  with  responder 
(C57BL/10) or nonresponder (DBA/1)  parental GAT-Mq~ responded to F1 and  the 
immunizing  parental  GAT-M<h,  but  failed  to  respond  to  the  opposite parental  or 
unrelated  third  party GAT-M<h  (Table II, exp.  1).  This  response  pattern  was  not 
altered  by addition  of soluble GAT  to  the  immunizing  C57BL/10  GAT-M<h,  but 
soluble GAT induces the same response pattern as C57BL/10 GAT-Mq~ in these F1 
mice and no alteration was expected. By contrast, soluble GAT completely reversed 
the response pattern in F1 mice immunized with DBA/1  GAT-Mq~.  Instead of being 
restricted  for and  responding  to  the  immunizing  DBA/1  GAT-Mth,  these  Fa  mice 
responded  identically to those immunized  with  soluble GAT alone and  developed 
PFC responses only when stimulated with responder parental C57BL/10 or Fx GAT- 
M<h (Table II, exp.  1). Further, the response patterns of F1 mice primed with F1 GAT- 
Mth (Exp. 2)  and GAT-MBSA (Exp. 3), which developed secondary responses when 
stimulated  with  either  parental  GAT-M~,  were  altered  in  a  similar  manner  by 
inclusion of soluble GAT in the immunizing regimen. These F1 spleen cells responded 
to responder parental C57BL/10 and  F1 GAT-Mq>,  but  no longer responded to the 
nonresponder parental DBA/1 GAT-M~. 
These experiments clearly demonstrate that the physical state of the GAT used for 1286  SUPPRESSOR  T  CELLS  IN  FI  SPLEEN  CELLS 
TAnLE  II 
Effects of Soluble GA T on Priming Patterns of Parental Responder, Nonresponder  and F1 GA T-Mdp, and 
GAT-MBSA in Responder ×  Nonresponder (C57BL/ lO ×  DBA/ I)F1 Mice 
(C57BL/10  X  DBA/1)FI Spleen cells 
Day 5 IgG GAT-specific PFC/culture* 
C57BL/10  DBA/1  (C57BL/10  C3H/He 
MO  M~  ×  DBA/1)F~  M~ 
M,~ 
Experiment  1 
Virgin 
GAT primed[I 
C57BL/10 GAT-Mq) primed¶ 
C57BL/10  GAT-M(h  +  10  #g  soluble  GAT 
primed** 
DBA/I GAT-Mth primed¶ 
DBA/1  GAT-M~  +  10  p,g  soluble  GAT 
primed** 
Experiment  2 
Virgin 
GAT primed]] 
(C57BL/10  ×  DBA/1)F1 GAT-Mq) primed¶ 
(C57BL/10  ×  DBA/1)F~  GAT-Mth  +  10  #g 
soluble GAT primed** 
Experiment  3 
Virgin 
GAT primed[] 
GAT-MBSA primed:]::~ 
GAT-MBSA +  l0/~g soluble GAT primed§§ 
980  800  900  1270 
(980)$  (750)  ND§  ND 
610  50  760  40 
(790)  (< 10)  ND  ND 
800  50  620  30 
540  <10  500  <10 
40  460  680  <10 
920  <10  870  40 
350  420  320  430 
(360)  (570) 
650  <10  680  <10 
(56O)  (<10) 
620  780  630  80 
330  <10  370  <10 
550  530  370  390 
310  40  310  40 
330  320  350  <10 
340  50  270  <10 
* Virgin or immune spleen cells at  10  7 cells/culture were incubated with 5  ×  104 of the indicated GAT- 
Mq) bearing =*4 ng GAT/10  s cells. 
:~ Numbers in parentheses are PFC responses stimulated by 5  x  104 C57BL/10 or DBA/1 M~ pulsed in 
vivo by injection of l0/~g GAT containing 1% 12SI-GAT into peritoneal cavities of mice 3 days after 
injection of 1.5 ml  10% proteose peptone. After  1 h, peritoneal exudate cells were harvested, washed 
three times with Hanks' balanced salt solution, and adjusted to 5  ×  105 cells/ml for addition to cultures 
in 0.1  ml  vol.  GAT/5  ×  104 cells  was:  experiment  1 --  C57BL/10  --  2.9  ng,  DBA/1  --  1.9  ng; 
experiment 2 -- C57BL/10 -- 3.5 ng, DBA/1 -- 3.0 ng. 
II (C57BL/10  ×  DBA/I)F1 mice were immunized 28 days previously by intraperitoneal injection of 10 
/~g GAT in Maalox-pertussis. 
¶ (C57BL/10  ×  DBA/I)F1 mice were immunized 28 days previously by intraperitoneal injection of 4  × 
10  n C57BL/10, DBA/I, or F1 GAT-Mq) bearing ~30 ng GAT/10  n cells. 
** (C57BL/10  ×  DBA/1)FI mice were immunized 28 days previously by intraperitoneal injection of 4 
6  6  ×  10  C57BL/10, DBA/I, or F1 GAT-Mth bearing ~30 ng GAT/10  cells plus 10 #g soluble GAT. 
~::]: (C57BL/10  ×  DBA/1)F1 mice were immunized 28 days previously by intraperitoneal injection of 10 
#g GAT as GAT-MBSA. 
§§ (C57BL/10  ×  DBA/1)F1 mice were immunized 28 days previously by intraperitoneal injection of l0 
~g GAT as GAT-MBSA plus 10/Lg soluble GAT. 
§ ND, not done. 
immunization  is  critical  in  determining  the  subsequent  response  pattern  of  the 
immune  FI spleen cells. Further, soluble GAT  can alter response patterns  induced  by 
parental  or F1 GAT-Mth  such that  these immune  spleen cells respond  as if they were 
immunized  with  soluble  GAT  alone.  Because  these  F1  mice  can  develop  secondary 
responses to nonresponder  parental  GAT-M(h after immunization  with these M~, but CARL W.  PIERCE  AND JUDITH A.  KAPP  1287 
TABLE  III 
Suppressor Cells m GAT and F1 GAT-Mck Primed Responder X  Nonresponder (C57BL/10  × 
DBA/1)Ft Spleen Cells 
F1 spleen cells (X 10-°)/culture  Day 5 IgG GAT-specific PFC/culture* 
GAT  F1 GAT-M~  C57BL/10  DBA/I  (C57BL/10  ×  C3H/He 
Virgin  primed:]:  primed:l:  Mq~  Mth  DBA/I)F1 M<h  M<h 
10  --  --  480  570  420  400 
14  --  --  330  350  290  420 
--  10  --  540  30  620  40 
--  --  10  610  520  530  <10 
10  4  --  400  30  490  <10 
10  --  4  480  460  440  <10 
* Virgin or immune (C57BL/10  ×  DBA/1)FI spleen cells were incubated with 5  ×  104 of the indicated 
GAT-M~k bearing ~2 ng GAT/10  s cells. 
(C57BL/10  ×  DBA/I)FI mice were immunized 35 days previously by intraperitoneal injection of 10 #g 
GAT in Maalox-pertussis  (CAT primed)  or 3  ×  106 F1 GAT-M~ bearing ;t20 ng GAT/10  n cells  (FI 
GAT-Mqb primed). 
TABLE  IV 
Suppressor Cell Activity in GA T-Primed Responder X  Nonresponder (C57BL/ lO X  DBA/1)Fx Spleen 
Cells is due to T Cells 
FI Spleen cells (× 10-e')/culture  Day 5 IgG GAT-specific PFC/culture* 
GAT-  Anti-Thy 1  DBA/I  (C57BL/10  ×  C3H 
Virgin  Primed:l:  +  C Treated  C57BL/10 M<k  M~  DBA/I)FI Mq,  Mq) 
GAT-Primed 
10  --  --  290  240  240  260 
14  --  --  290  210  280  240 
--  10  --  710§  10  630  60 
--  --  10  <10~  NDII  ND  ND 
10  4  --  250  40  190  <10 
10  --  4  230  250  190  220 
* Virgin or immune (C57BL/10  ×  DBA/I)F1 spleen  cells at the indicated cell densities  were incubated 
with 5 ×  104 of the indicated GAT-M(~ bearing -- l ng GAT/10  s cells. 
:~ (C57BL/10  ×  DBA/1)FI mice were immunized 28 days previously by intraperitoneal injection of l0/.tg 
GAT in Maalox-pertussis. 
§ Primary  IgM responses  to SRBC by these spleen  cells:  GAT-primed,  1570; anti-Thy  l  +  C  treated 
GAT-primed, 140. 
[[ ND, not done. 
soluble GAT  reverses  this response  pattern,  the  possibility of suppressor  cell activity 
induced  by  soluble  GAT  in  these  (responder  ×  nonresponder)F1  mice  was  investi- 
gated. 
Suppressor  Cells  in  (Responder  ×  Nonresponder)F1  Spleen  Cells  Primed  With  Soluble 
GAT.  Because primary  PFC  responses  to  GAT  are  not  governed  by restrictions  on 
M(k-lymphocyte interactions  (6,  14), primed  FI spleen cells can be added  to virgin Ft 
spleen cells stimulated  with various GAT-Mq~ to test  for suppressor  cell activity (14). 
Small numbers  of soluble GAT-primed  F1 spleen cells, whose responses  are restricted 
to  F1  or responder  parental  GAT-M~,  suppressed  responses  of virgin  Fa  spleen  cells 
stimulated  by nonresponder  parental  DBA/1,  or third party C3H/He  GAT-Mq~, but 
not responses stimulated  by F1 or responder parental  GAT-Mth (Table III). However, 
F1 spleen cells from mice primed with F1 GAT-M~  did not suppress responses of virgin 1288  SUPPRESSOR T CELLS IN F1  SPLEEN CELLS 
F1 spleen cells stimulated with nonresponder parental GAT-M~, but had suppressor 
cells that were activated by unrelated third party C3H/He GAT-Mq~. Treatment of 
GAT-primed Fa spleen cells containing suppressor  cells with anti-Thy 1.2 serum plus 
C abolished the suppression  demonstrating that the suppression  was T-cell mediated 
(Table IV). 
Discussion 
Three significant observations emerged from these  experiments. First,  (responder 
X  nonresponder)Fx  spleen  cells from mice immunized with F1 GAT-Mq~ or GAT- 
MBSA develop  secondary PFC responses when stimulated with responder and non- 
responder parental GAT-Mff, but not when stimulated with unrelated third party 
C3H/He GAT-M~. These observations are in contrast to responses of soluble GAT- 
primed F1 spleen cells, which respond to F1 and responder parental GAT-Mq~ but not 
to nonresponder parental GAT-Mq~, and emphasize the critical importance of the 
physical state of the GAT used for immunization in determining subsequent response 
patterns of F1 spleen  cells. The observations with F1 spleen  cells from mice primed 
with F1 GAT-Mq~ and GAT-MBSA are consistent with responses of F1 spleen  cells 
from mice primed with nonresponder parental GAT-Mq~ and demonstrate further 
that F1 mice have T  cells that can be primed by and subsequently respond to GAT 
presented on nonresponder parental Mq~. Collectively, these observations argue against 
functional expression of the Ir genes controlling the response to GAT in Mdp. 
Second,  spleen  cells from  (responder  ×  nonresponder)F1  mice immunized with 
GAT-Mq~ or GAT-MBSA plus soluble GAT develop secondary PFC responses when 
stimulated with Fx or responder parental GAT-M~, but not nonresponder parental 
GAT-Mff, regardless  of the response  pattern of the Fa spleen  cells immunized with 
GAT-Mff or  GAT-MBSA  alone.  Thus,  soluble  GAT  does  not  alter  the  response 
pattern of spleen cells from mice immunized with responder parental GAT-Mdp which 
normally respond only to those GAT-Mq~. However, soluble GAT clearly modulated 
the secondary response  patterns of F~ spleen  cells immunized simultaneously with 
nonresponder parental or F1 GAT-Mq~ or GAT-MBSA such that these Fa spleen cells 
no  longer respond  to  nonresponder parental  GAT-Mdp. These  observations  again 
demonstrate  the  critical  importance  of the  physical  state  of the  GAT  used  for 
immunization and further demonstrate that soluble  GAT can block priming of T 
cells which are normally primed and respond to subsequent stimulation with nonre- 
sponder parental GAT-Mq~. 
Third,  soluble  GAT-primed  (responder  ×  nonresponder)Fl  spleen  cells  have  a 
population of suppressor  T  cells which inhibit primary PFC responses  of virgin F1 
spleen  cells stimulated with nonresponder parental GAT-Mq~. Thus, soluble  GAT 
stimulates at least  two populations of T  cells in F1 mice;  one functions as helper T 
cells for responses stimulated by responder parental GAT-Mq~, the other functions as 
suppressor T cells in responses of virgin Fa spleen cells to nonresponder parental and 
unrelated GAT-Mdp. By contrast, spleen cells from Fa mice immunized with F1 GAT- 
M~ have helper T cells which can be stimulated by both responder and nonresponder 
parental GAT-M~ and suppressor T cells which are active in suppressing  responses of 
virgin F1 spleen cells stimulated with unrelated third party C3H/He GAT-M~. This 
last observation is consistent  with results where suppressor T-cell activity is elicited in 
spleen cells from responder mice immunized with syngeneic or allogeneic GAT-Mq~ 
by any GAT-Mq~ allogeneic  to the Mq~ used for immunization (8). The behavior of CARL W.  PIERCE AND JUDITH  A.  KAPP  1289 
these suppressor T  cells suggests they recognize GAT alone and not in the context of 
a M~ membrane complex. 
These apparently paradoxical observations can  be reconciled by considering the 
immunobiology of Ir gene control of antibody responses to GAT and the concept that 
subsets of T cells exist in Ft animals, each of which is capable of interacting with one, 
but  not  the  other,  parental  M~  (17-19).  Responder  strains  of  mice,  including 
(responder  ×  nonresponder)F1 mice, develop GAT-specific, radioresistant helper T 
cells after immunization with soluble GAT, GAT-Mq~, and GAT-MBSA that function 
only when stimulated by GAT presented on Mq~ syngeneic to the Mq~ which presented 
the GAT during the in vivo immunization process (2-4, 6, 8). Radiosensitive, GAT- 
specific suppressor T  cells are present in these populations of immune T  cells which 
suppress  primary PFC  responses stimulated  by GAT on  M~  allogeneic to the  M~ 
which  presented GAT during the immunization  process  (8).  Thus,  responder mice 
can develop both GAT-specific helper and suppressor T cells after immunization with 
GAT. In nonresponder mice, soluble GAT preferentially stimulates suppressor T  cells 
which appear to block or inhibit the development of helper T  cells (1-4). However, 
because nonresponder mice can develop radioresistant, GAT-specific helper T  cells 
after immunization with GAT-Mq~ and GAT-MBSA (2-4), the defect in nonresponder 
mice is not a failure of T  cells to recognize GAT or a lack of the capacity to develop 
helper cells.  However, simultaneous administration of soluble GAT and GAT-MBSA 
to nonresponder mice abrogates development of helper T  cells and only suppressor T 
cells  are  demonstrated  (1-3).  Thus,  as  in  responder mice,  nonresponder mice can 
develop both helper and suppressor T  cells specific for GAT, but the physical state of 
the GAT (soluble vs. insoluble as GAT-Mq~ or GAT-MBSA) appears to be the major 
factor determining whether helper or suppressor T  cells predominate. This suggests 
that the Ir gene product does not encode a recognition unit for GAT, but functions as 
a  regulatory gene after recognition of GAT by the  T  cells.  Further,  GAT-specific 
suppressor T  cells in both responder and nonresponder mice are unable to inhibit the 
function of immune helper cells, but  readily inhibit stimulation  of virgin helper T 
cells and  therefore the  development of primary  PFC  responses  (1-3,  8).  This may 
account for the failure of nonresponder mice immunized with soluble GAT to develop 
either primary PFC responses or helper T  cells. 
Distinct subsets of T  cells, each capable of interacting with antigen presented on 
one but not  the other parental  Mq~ have been demonstrated in F1 guinea pigs  (17) 
and  mice  (18,  19).  Because  both  responder  and  nonresponder  parental  mice  can 
develop helper and suppressor T cells after exposure to the appropriate form of GAT, 
extension of the F1 T-cell subset  concept leads to the hypothesis that  in  (responder 
×  nonresponder)F1  mice,  subsets  of T  cells exist  which,  after immunization  with 
soluble GAT, behave functionally as responder or nonresponder parental T  cells and 
that a phenotypic or functional allelic exclusion of the Ir gene function occurs in these 
subsets. Many of the predictions of this hypothesis have been borne out in the present 
experiments. First,  immunization of F1 mice with F1 GAT-M~ stimulates helper T 
cells capable of being stimulated by either parental GAT-M~, whereas immunization 
with  either parental  GAT-Mq~ alone stimulates  helper cells capable of responding 
subsequently only to the immunizing parental GAT-Mq~.  Thus, the two subsets of T 
cells which function as helper T  cells with the appropriate parental GAT-M~ have 
been  demonstrated.  Moreover,  suppressor  T  cells  which  inhibit  responses  to  Mq~ 
allogeneic to those used for immunization have been demonstrated in F1 spleen cells 1290  SUPPRESSOR T CELLS IN Fa  SPLEEN CELLS 
of mice immunized by F1 GAT-Mq) as predicted. After immunization with soluble 
GAT, F1 spleen cells contain helper cells which function only when stimulated with 
responder parental GAT-M~ and, most significantly, contain suppressor T cells which 
function with nonresponder parental GAT-M~ as well as unrelated GAT-M~. Thus, 
subsets of T  cells are stimulated in FI mice by soluble GAT which behave phenotyp- 
ically as  responder  parental  (helper  cells)  and  nonresponder  parental  (suppressor 
cells). Definitive proof of the hypothesis awaits experiments selecting the four respec- 
tive subsets of T  cells in these F1 mice. 
Summary 
The ability of spleen cells from  (responder  X  nonresponder)F1 mice immunized 
with various GAT-M~, GAT-MBSA, and soluble GAT to develop IgG GAT-specific 
PFC responses in vitro after stimulation with responder and nonresponder parental 
and F1 GAT-Mq, was investigated. F1 spleen cells from mice immunized with F1 GAT- 
M~ or GAT-MBSA developed secondary responses to responder and  nonresponder 
parental and  Fa GAT-Mq), but  not to unrelated third party GAT-Mq). Spleen cells 
from F1 mice immunized with either parental GAT-M~ developed secondary responses 
to  F1  GAT-M~  and  only  the  parental  GAT-M~  used  for  immunization  in  vivo. 
Soluble GAT-primed F1 spleen cells responded to F1 and responder parental, but not 
nonresponder  parental,  GAT-M~.  Simultaneous  immunization  in  vivo  with  the 
various GAT-Mq) or GAT-MBSA plus soluble GAT modulated the response pattern 
of these F1 spleen cells such that they developed secondary responses only to FI and 
parental  responder GAT-Mq) regardless of the  response pattern  observed after im- 
munization  with  the  various  GAT-M~  or  GAT-MBSA  alone.  These observations 
demonstrate  the  critical  importance  of the  physical  state  of the  GAT  used  for 
immunization in determining the subsequent response pattern of immune F1 spleen 
cells to the parental and F1 GAT-Mq). Further, suppressor T cells, capable of inhibiting 
primary  responses  to  GAT  by  virgin  F1  spleen  cells  stimulated  by  nonresponder 
parental GAT-M~, were demonstrated in spleens of F1 mice immunized with soluble 
GAT,  but  not  those  primed  with  F1  GAT-Mq).  Because  responder  parental  mice 
develop both helper and suppressor T  cells after immunization with GAT-Mq), and 
soluble GAT preferentially stimulates suppressor T  cells whereas GAT-M~ stimulate 
helper T  cells in nonresponder parental mice, these observations suggest that distinct 
subsets  of T  cells exist  in  F1  mice which  behave phenotypically as  responder and 
nonresponder parental T  cells after immunization with soluble GAT and GAT-M~. 
We thank Ms. Rita Allen and Isabel Diego for their expert technical  assistance and Ms. Sally 
Menkhus and Vicki Ferguson for preparation of this manuscript. 
Received  for publication 12June 1978. 
References 
1.  Kapp, J. A., C. W.  Pierce, S.  Schlossman,  and B.  Benacerraf.  1974. (]enetic control of 
immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by 
the terpolymer of L-glutamic acidS°-L-alaninea°-L-tyrosine  TM ((;AT). J. Exp.  Med. 140:648. 
9.  Pierce, C. W., and J. A. Kapp.  1976. Regulation of immune responses by suppressor  T 
cells. Contemp. Top. Immunobiol. 5:91. 
3.  Pierce, C. W., and J. A. Kapp.  1978. L-glutamie acide°-L-alanine3°-L-tyrosine  1° ((]AT): a 
probe for regulatory mechanisms in antibody responses. In Immunobiology of Proteins and CARL W.  PIERCE AND JUDITH A.  KAPP  1291 
Peptides I. M. Z. Atassi and A. B. Stavitsky, editors. Plenum Publishing Corp. New York. 
419. 
4.  Kapp, J. A., C. W. Pierce, and B. Benacerraf.  1975. Genetic control of immune responses 
in vitro. VI. Experimental conditions for the development of helper T-cell activity specific 
for the terpolymer of L-glutamic acid~°-L-alanine~°-L-tyrosine  1° (GAT)  in  nonresponder 
mice. J. Exp.  Med.  142:50. 
5.  Pierce, C. W., J.  A.  Kapp,  D. D. Wood, and  B. Benacerraf.  1974. Immune responses in 
vitro. X. Functions of macrophages.J. Immunol. 112:1181. 
6.  Pierce, C. W., J. A. Kapp, and B. Benacerraf.  1976. Regulation of macrophage-lymphoid 
cell interactions in secondary antibody responses in vitro.J. Exp.  Med.  144"1382. 
7.  Pierce,  C.  W.,  and  J.  A.  Kapp.  1978. H-2  gene  complex  regulation  of macrophage- 
lymphocyte interaction in antibody responses  in vitro. In Ir Genes and Ia Antigens. H. O. 
McDevitt, editor. Academic Press, Inc., New York. 357. 
8.  Pierce,  C.  W.,  and  J.  A.  Kapp.  1978. Antigen-specific  suppressor  T  cell  activity  in 
genetically restricted immune spleen cells.J. Exp.  Med.  148:1271. 
9.  Shevach, E. M., and A. S. Rosenthal. 1973. Function ofmacrophages in antigen recognition 
by guinea pig T  lymphocytes. II. Role of the macrophage in  the  regulation  of genetic 
control of the immune response..]. Exp.  Med.  138:1213. 
10.  Miller,  J.  F.  A.  P.,  M.  A.  Vadas,  A.  Whitelaw,  J.  Gamble,  and  C.  Bernard.  1977. 
Histocompatibility linked  immune responsiveness  and restrictions  imposed on sensitized 
lymphocytes.J. Exp. Med.  145:1623. 
11.  Singer, A., C. Cowing, K. S. Hatcock, H. B. Dickler, and R. J. Hodes.  1978. Cellular and 
genetic control of antibody responses  in  vitro.  III. Immune response gene regulation  of 
accessory cell function of non-T, non-B spleen adherent cells.J. Exp.  Med.  147:1611. 
12.  Marrack, P., and J. Kappler.  1978. The role of H-2 linked genes in helper T  cell function. 
III. Expression of immune response genes for trinitrophenyl conjugates of poly-L(tyr,glu)- 
poly D,L-ala--poly-L-lys in B cells and macrophages.J. Exp.  Med.  147-1596. 
13.  Rosenthal, A. S.  1978. Determinant selection and macrophage function in genetic control 
of the immune response, lmmunol. Rev. 40:136. 
14.  Pierce,  C. W., R. N. Germain, J. A. Kapp, and B. Benacerraf.  1977. Secondary antibody 
responses  in  vitro to L-glutamic acidS°-L-alanine3°-L-tyrosine  1° (GAT)  by (responder  × 
nonresponder)F1  spleen  cells  stimulated  by  parental  GAT-macrophages. J.  Exp.  Med. 
140:1827. 
15.  Kapp, J. A., C. W. Pierce, and B. Benacerraf.  1973. Genetic control of immune responses 
in vitro. I.  Development of primary and  secondary plaque-forming cell  responses to the 
random terpolymer L-glutamic aeid6°-L-alaninea°-L-tyrosine  1° (GAT) by mouse spleen cells 
in vitro. J. Exp. Med.  138:1107. 
16.  Pierce, C. W., B. M. Johnson, H. E. Gershon, and R. Asofsky.  1971. Immune responses in 
vitro.  Ill.  Development of primary yM, "~, yA plaque-forming cell  responses in mouse 
spleen cell cultures stimulated with heterologous erythrocytes.J. Exp.  Med.  134:395. 
17.  Paul,  W.  E.,  E.  M.  Shevach,  S.  Pickeral,  D.  W.  Thomas,  and  A.  S.  Rosenthal.  1977. 
Independent populations of  primed F~ guinea pig T !ymphocytes respond to antigen-pulsed 
parental peritoneal exudate cells.,].  Exp.  Med.  145"618. 
18.  Swierkosz,  J. E., K. Rock, P. Marrack, and J. W. Kappler.  1978. The role of H-2 linked 
genes in helper T cell function. II. Isolation on antigen pulsed macrophages of two separate 
populations  of FI helper T  cells  each specific for antigen  and  one set  of parental  H-2 
products. J. Exp. Med.  147:554. 
19.  Miller,  J.  F.  A.  P.,  M.  A.  Vadas,  A.  Whitelaw,  and J.  Gamble.  1976. Role  of major 
histocompatibility complex gene products in delayed hypersensitivity. Proc. Natl.  Acad. ScL 
U. S. A. 75:5095. 